Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02477267 · ClinicalTrials.gov registry record · Phase 1
Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers
A Phase 1 study, sponsored by INSYS Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 47
- Enrollment target
NCT02477267 is a Phase 1 study that has completed, run by INSYS Therapeutics. The registered enrollment target is 47 participants.
The verdict
NCT02477267, a Phase 1 study, has completed, sponsored by INSYS Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 47 participants
- Enrollment target
Study Summary
The primary objective of this study is to compare the bioavailability of a test formulation of Buprenorphine Naloxone Sublingual (SL) spray to that of a single dose of Suboxone® (buprenorphine and naloxone) sublingual film, under fasted conditions.
Interventions
- DRUG SL spray
- DRUG SL film
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2015-06 |
| Est. Completion | 2015-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02477267
The ClinicalTrials.gov registry entry for NCT02477267 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is INSYS Therapeutics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SL spray is the first listed.
NCT02477267 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02477267 about?
NCT02477267 is a clinical study titled "Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers". The primary objective of this study is to compare the bioavailability of a test formulation of Buprenorphine Naloxone Sublingual (SL) spray to that of a single dose of Suboxone® (buprenorphine and naloxone) sublingual film, under fasted conditions.
What is the current status of trial NCT02477267?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 47 participants. The study started on 2015-06. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02477267?
The interventions under investigation include: SL spray (DRUG), SL film (DRUG).
Who is sponsoring clinical trial NCT02477267?
This trial is sponsored by INSYS Therapeutics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.